Enhanced stereotyped response to apomorphine after chronic D-1 blockade with SCH 23390
- 1 January 1987
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 91 (3) , 394-396
- https://doi.org/10.1007/bf00518199
Abstract
Rats were treated for 21 days with the selective D-1 blocker SCH 23390 (0.1 mg/kg SC). Threshold doses of apomorphine for hypermotility (0.15 mg/kg SC) and for stereotyped response (0.25 mg/kg SC) were given 7, 21, 35, and 77 days after discontinuation of the chronic treatment. The rats always showed enhanced stereotyped response to the higher dose of apomorphine but never any change in their motility response to the lower dose of dopamine agonist. This finding may represent a behavioral correlate of the reported supersensitivity of D-1 receptors induced by SCH 23390.This publication has 14 references indexed in Scilit:
- [3H]SCH 23390 binding sites increase after chronic blockade of D-1 dopamine receptorsEuropean Journal of Pharmacology, 1985
- Hyperactivity induced by stimulation of separate dopamine D-1 and D-2 receptors in rats with bilateral 6-OHDA lesionsLife Sciences, 1985
- SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptorsBiochemical Pharmacology, 1985
- Increased or decreased locomotor response in rats following repeated administration of apomorphine depends on dosage intervalPsychopharmacology, 1985
- Selective D-1 dopamine receptor increase following chronic treatment with SCH 23390European Journal of Pharmacology, 1985
- Distinct effects of two stresses on the behavioral response to apomorphineLife Sciences, 1984
- Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neurolepticsLife Sciences, 1984
- SCH 23390—The first selective dopamine D-1 antagonistEuropean Journal of Pharmacology, 1983
- Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (−)-sulpiride and haloperidolEuropean Journal of Pharmacology, 1982
- On the mode of action of apomorphineEuropean Journal of Pharmacology, 1973